Lung cancer disease burden and changing trends of residents in Yinchuan City in 2013-2022
10.3969/j.issn.1006-2483.2025.05.010
- VernacularTitle:2013—2022银川市居民肺癌疾病负担及变化趋势分析
- Author:
Xiaoxia WANG
1
;
Rongrong LIN
1
;
Ning HUI
1
Author Information
1. Yinchuan Centre for Disease Control and Prevention ,Yinchuan , Ningxia 750002 , China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
Disease burden;
Changing trends
- From:
Journal of Public Health and Preventive Medicine
2025;36(5):45-49
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the change trend of lung cancer death, incidence and disease burden of residents in Yinchuan City from 2013 to 2022, and to provide a scientific basis for the prevention and treatment of lung cancer in Yinchuan City. Methods The lung cancer registration data of residents in Yinchuan City from 2013 to 2022 were collected and sorted to obtain the incidence and mortality rates of lung cancer. The years lived with disability (YLD), years of life lost (YLL), and disability adjusted of life years（DALY) were calculated. The Joinpoint regression model was used to analyze the trend of onset and death of lung cancer. Results The lung cancer incidence rate, standardized incidence rate, mortality rate, standardized mortality rate, YLL rate, YLD rate and DALY rate among Yinchuan residents from 2013 to 2022 all showed a fluctuating upward trend. During the 10 years from 2013 to 2022, the average annual percent change (AAPC) of the above indicators was 1.24%, 1.04%, 6.94%, 6.11%, 8.99%, 0.93%, and 8.95%, respectively. In the past 10 years, the above indicators showed a rapid upward trend with age, especially in the age group over 45 years old. The analysis also showed that all indicators were much higher in men than in women. The YLL was the main component of DALY, accounting for more than 75%. Conclusion During the period of 2013-2022, the disease burden caused by lung cancer in Yinchuan City is relatively heavy. People over 45 years old, especially men, should become the key prevention and control group. Scientific and effective intervention measures should be taken to further promote the early diagnosis and treatment of lung cancer and reduce the burden of lung cancer.
